Please use this identifier to cite or link to this item: https://ah.lib.nccu.edu.tw/handle/140.119/118001
題名: A Small Detail in the Specification May Save “Molecular Weight” from Being Held Indefinite: A Lesson from Reckitt Benckiser Pharm. Inc. v. Watson Labs., Inc.
作者: 陳秉訓
Chen, Ping-Hsun
貢獻者: 科管智財所
日期: Oct-2017
上傳時間: 25-Jun-2018
摘要: AbstractTeva Pharms. USA, Inc. v. Sandoz, Inc., 789 F.3d 1335 (Fed. Cir. 2015), indicates that “molecular weight” may be an indefinite claim term for polymer-related claims if the specification fails to provide the definition of “molecular weight.” Since Teva Pharms. USA, Inc., whether “molecular weight” is an indefinite claim term has become an issue in litigation concerning polymer-related patents. This article reports Reckitt Benckiser Pharm. Inc. v. Watson Labs., Inc., No. CV 13-1674-RGA, 2016 WL 3186659 (D. Del. June 3, 2016), where the court relied on a footnote of one table in the specification to hold the disputed term “molecular weight” definite. Such footnote merely disclosed the name of the company that manufactured the claimed polymer related to the dispute term. This article argues that while a small detail in the specification may save “molecular weight” from being held indefinite, it is better to disclose the molecular weight definition provided by the manufacturer.
關聯: Biotechnology Law Report, Vol.36, No.5, pp.223-228
資料類型: article
DOI: https://doi.org/10.1089/blr.2017.29040.phc
Appears in Collections:期刊論文

Files in This Item:
File Description SizeFormat
index.html106 BHTML2View/Open
Show full item record

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.